| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 05/02/2007 | CN1956971A Novel fused heterocycles and application thereof |
| 05/02/2007 | CN1956964A Tetrahydro-indazole cannabinoid modulators |
| 05/02/2007 | CN1956955A Neurogenic pain control agent composition |
| 05/02/2007 | CN1956954A Novel androgens |
| 05/02/2007 | CN1956952A Histamine H3 receptor agents, preparation and therapeutic uses |
| 05/02/2007 | CN1955178A New benzimidazole derivative |
| 05/02/2007 | CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/02/2007 | CN1313472C Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such |
| 05/02/2007 | CN1313465C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 05/02/2007 | CN1313450C Tachykinin receptor antagonists |
| 05/02/2007 | CN1313448C Metalloproteinase inhibitors |
| 05/01/2007 | USRE39608 Substituted benzimidazoles and their use as PARP inhibitors |
| 05/01/2007 | US7211675 2-(2H-Benzotriazole-2-yl)-4-bromomethylphenol; polymer stabilizer, compatible with polyolefins, polycarbonate, polystyrene and diene-elastomers |
| 05/01/2007 | US7211669 therapy for depression; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches; drug addition; antiinflammatory agents |
| 05/01/2007 | US7211653 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases |
| 05/01/2007 | US7211601 Prevention labor contraction; urogenital disorders |
| 05/01/2007 | US7211600 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 05/01/2007 | US7211594 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 05/01/2007 | US7211587 Administering compounds such as N-{3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)-oxy]phenyl}-N'-(3-isoxazolyl)urea for therapy of malignant tumors |
| 05/01/2007 | US7211581 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 05/01/2007 | US7211580 Compounds, compositions, and methods |
| 05/01/2007 | US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity |
| 05/01/2007 | US7211577 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 05/01/2007 | CA2244836C Benzoheterocyclic derivatives as antidiabetic and antiobesity agents |
| 04/26/2007 | WO2007047838A2 Process for preparing olmesartan medoxomil |
| 04/26/2007 | WO2007047775A1 Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 04/26/2007 | WO2007047306A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 04/26/2007 | WO2007047177A1 Acyl indoles, compositions containing such compounds and methods of use |
| 04/26/2007 | WO2007046747A1 Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases |
| 04/26/2007 | WO2007046550A1 Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity |
| 04/26/2007 | WO2007045877A1 4-heteroarymethyl substituted phthalazinone derivatives |
| 04/26/2007 | WO2007045861A1 Cinnoline compounds as inhibitors of phosphodiesterase type iv (pde4) |
| 04/26/2007 | WO2007045393A1 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | WO2007045184A1 The peptides essence receptor antagonist which 2-site containing proline or crico-amino acid |
| 04/26/2007 | WO2007023382A3 Pyrimidine amino pyrazole compounds, potent kinase inhibitors |
| 04/26/2007 | WO2007011696A3 Compositions and methods for coupling a plurality of compounds to a scaffold |
| 04/26/2007 | WO2006136606A3 Oxindole derivatives |
| 04/26/2007 | WO2006135828A3 Trisubstituted amines as phosphodiesterase 4 inhibitors |
| 04/26/2007 | WO2006117307B1 Benzotriazole derivatives as cannabinoid receptor antagonists |
| 04/26/2007 | WO2006099075A3 Certain substituted amides, method of making, and method of use thereof |
| 04/26/2007 | WO2006031676A3 Tricyclic anilide spirohydantoin cgrp receptor antagonists |
| 04/26/2007 | WO2004069139A3 4-aminopyrimidin-5-yl-methanone derivatives for inhibition of cdk4 activity |
| 04/26/2007 | US20070093544 1-((4-Tert-butylcyclohexyl)(1-methyl-5-propoxy-1H-benzimidazol-2-yl-amino-)-N-1H-tetrazole-5-yl-indane-5-carboxamide; glucagon receptor antagonists; antidiabetic agents; type 2 diabetes mellitus; insulin resistance; gluconeogenesis inhibitors; lowering rate of hepatic glucose output; hypoglycemic agents |
| 04/26/2007 | US20070093540 process for the preparation of angiotensin ii antagonistic compounds |
| 04/26/2007 | US20070093534 Modulation of Pathogenicity |
| 04/26/2007 | US20070093533 Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same |
| 04/26/2007 | US20070093532 Benzimidazole carboxamides as raf kinase inhibitors |
| 04/26/2007 | US20070093531 Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them |
| 04/26/2007 | US20070093530 Substituted indolealkanoic acids |
| 04/26/2007 | US20070093529 Diacylhydrazine derivatives |
| 04/26/2007 | US20070093526 4-Amino-piperidine derivatives as monoamine uptake inhibitors |
| 04/26/2007 | US20070093523 Tetrahydroisoquinoline LXR modulators |
| 04/26/2007 | US20070093522 To treat pain, drug addiction, or tinnitus; selectively inhibit sodium or calcium ion channels and agonize or antagonize mu -opioid receptors; N-Benzyl-N-(2-dimethylamino-ethyl)-2-(S)-[3-(4-fluorophenyl)-ureido]-3-methyl-butyramide |
| 04/26/2007 | US20070093515 Phosphodiesterase 10 inhibitors |
| 04/26/2007 | US20070093506 Inhibitors of tyrosine kinases |
| 04/26/2007 | US20070093505 2,3-Substituted 5,6-diaryl-pyrazine derivatives as cb1 modulators |
| 04/26/2007 | US20070093502 5- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 04/26/2007 | US20070093500 adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms; 4,5,6,7-tetrafluoro-2-{4-[4-(2-isopropoxy-phenyl)-piperazin-1-yl]-cyclohexyl}-isoindole-1,3-dione |
| 04/26/2007 | US20070093492 Pyrrolidine derivatives |
| 04/26/2007 | US20070093485 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 04/26/2007 | US20070093484 3-Substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators |
| 04/26/2007 | US20070093483 Use of derivatives of 2, 4-dihydro-[1,2,4] triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo) |
| 04/26/2007 | US20070093479 6-chloro-N-(3,3-dimethylbutyl)-5-phenyl-1H-indazol-3-amine; for treating neurodegenerative diseases such as Alzheimer's, fronto-parietal dementia, Pick's disease, Parkinson's disease, type II diabetes, corticobasal degeneration, in which phosphorylation of the tau protein is observed |
| 04/26/2007 | US20070093478 Novel mycobacterial inhibitors |
| 04/26/2007 | US20070093475 Short-acting benzodiazepines |
| 04/26/2007 | US20070093473 7-Heteroarylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
| 04/26/2007 | US20070093472 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors xa and viia for the treatment of thromboses |
| 04/26/2007 | US20070093467 2-(4-Chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-1-[4-(4-fluorobenzyl),4-hydroxypiperidin-1-yl]ethanone; potent chemokine receptor antagonists; antiinflammatory agents; immunotherapy; rheumatic diseases; antiarthritic agents; transplant rejection; multiple sclerosis |
| 04/26/2007 | US20070093454 sodium channel modulators, such as Isobutyl 4-(6-(2-hydroxyphenyl)pyrimidin-4-yl)piperazine-1-carboxylate, used as analgesics |
| 04/26/2007 | US20070092441 Fluoridation method |
| 04/26/2007 | DE102005049953A1 Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen Carbamoylbenzotriazol derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | CA2628577A1 Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases |
| 04/26/2007 | CA2626789A1 Pyrimidinones as casein kinase ii (ck2) modulators |
| 04/26/2007 | CA2626028A1 Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 04/26/2007 | CA2625722A1 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | CA2624904A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 04/26/2007 | CA2624166A1 Inhibitors of viral replication |
| 04/26/2007 | CA2624007A1 Acyl indoles, compositions containing such compounds and methods of use |
| 04/26/2007 | CA2623703A1 4-heteroarylmethyl substituted phthalazinone derivatives |
| 04/25/2007 | EP1777224A2 A process for the preparation of angiotensin II antagonistic compounds |
| 04/25/2007 | EP1776358A2 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase |
| 04/25/2007 | EP1776351A1 Uv filter |
| 04/25/2007 | EP1776339A2 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
| 04/25/2007 | EP1776337A2 Benzyloxy derivatives as maob inhibitors |
| 04/25/2007 | EP1776107A1 Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP1200824B1 Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives |
| 04/25/2007 | EP1040101B1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 04/25/2007 | EP1024138B1 Pyrazole derivatives |
| 04/25/2007 | CN1953976A Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain |
| 04/25/2007 | CN1953975A 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 04/25/2007 | CN1953974A Pyrimidine derivatives for the treatment of abnormal cell growth |
| 04/25/2007 | CN1953973A Preparation of candesartan cilexetil in high purity |
| 04/25/2007 | CN1953972A 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 04/25/2007 | CN1953967A Purification of progesterone receptor modulators |
| 04/25/2007 | CN1953965A Novel cis-imidazolines |
| 04/25/2007 | CN1312151C (imidazol-1-yl-methyl)-pyridazine as NMDA receptor blocker |
| 04/25/2007 | CN1312137C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 04/25/2007 | CN1312136C Triazole derivatives as tachykinin receptor antagonists |
| 04/25/2007 | CN1312134C 5-phenylpyrimidines, fungicide compositions comprising the same, method for producing and use thereof |